Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.
乐伐替尼联合抗程序性细胞死亡蛋白 1 在小鼠中的免疫调节作用及肝细胞癌患者富集的理论依据
期刊:Hepatology
影响因子:15.8
doi:10.1002/hep.32023
Torrens Laura, Montironi Carla, Puigvehà Marc, Mesropian Agavni, Leslie Jack, Haber Philipp K, Maeda Miho, Balaseviciute Ugne, Willoughby Catherine E, Abril-Fornaguera Jordi, Piqué-Gili Marta, Torres-MartÃn Miguel, Peix Judit, Geh Daniel, Ramon-Gil Erik, Saberi Behnam, Friedman Scott L, Mann Derek A, Sia Daniela, Llovet Josep M
